Heinonen, J. A., & Wilson, J. M. (2011). Pharmaceutical counterfeiting in the US: differentiating dimensions of the risk.
The creation of a product counterfeiting database highlights variation in known incidents of counterfeit pharmaceuticals across several important dimensions. By understanding how these incidents differ, researchers can provide empirical insights into the problem, develop evidence-based anti-counterfeit strategy and promote awareness to consumers, government and industry. This complex form of product counterfeiting involves offending specialists and generalists, has links to terrorist groups and puts the public’s health and safety at risk.
Also published in Global Edge Business Review at https://globaledge.msu.edu/content/gbr/gBR5-1.pdf.